Noreen Shaaban
Endocrinology, Diabetes & Metabolism · Doral, FLNPI 1760090740
Payments from drug & device makers
Across 703 payments — averaging $203.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$83K
- Vertex$51K
- Lilly USA, LLC$1K
- Amgen$774
- Boehringer Ingelheim$727
- Novo Nordisk$687
- plus $6K from 30 others
What the payments were for
- Food & beverage$9,520100%
- Education$430%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 283 | $82,519 |
| Vertex | 2 | $51,016 |
| Lilly USA, LLC | 60 | $1,144 |
| Amgen(2 entities) | 24 | $774 |
| Boehringer Ingelheim | 31 | $727 |
| Novo Nordisk | 30 | $687 |
| Mannkind Corporation | 29 | $653 |
| AstraZeneca(2 entities) | 15 | $554 |
| Novartis | 28 | $502 |
| Sanofi-aventis U.S. LLC | 27 | $461 |
| AbbVie | 24 | $439 |
| Dexcom, Inc. | 14 | $426 |
| Xeris Pharmaceuticals, Inc. | 22 | $391 |
| Bayer | 17 | $365 |
| Corcept Therapeutics | 14 | $360 |
| Kyowa Kirin, Inc. | 7 | $322 |
| Tandem Diabetes Care, Inc. | 10 | $284 |
| Radius Health, Inc. | 15 | $281 |
| Esperion Therapeutics, Inc. | 4 | $173 |
| Lifescan, Inc. | 9 | $155 |
| Pfizer | 7 | $134 |
| Cequr Corporation | 1 | $132 |
| Recordati_rare_diseases_inc. | 6 | $120 |
| Halozyme Inc | 5 | $101 |
| Ascendis Pharma Endocrinology Inc | 3 | $65 |
| Antares Pharma, Inc. | 3 | $54 |
| Amphastar Pharmaceuticals, Inc. | 2 | $46 |
| Amarin Pharma, Inc. | 2 | $45 |
| IBSA Pharma Inc. | 2 | $33 |
| Insulet Corporation | 1 | $25 |
| Ionis Pharmaceuticals, Inc. | 1 | $23 |
| Sequel Med Tech, LLC | 1 | $19 |
| Cardinal Health 414 LLC | 1 | $18 |
| Madrigal Pharmaceuticals | 1 | $17 |
| Roche Diabetes Care, Inc. | 1 | $16 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$143,097 in reported general payments places this provider in the 85th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
See all endocrinology, diabetes & metabolism providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Testosterone Cypionate | 24 | $636 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Doral
- Richard PratleyOrlando$9.2M
- Jose MandryOcoee$9.1M
- Steven SmithOrlando$7.9M
- Barry HorowitzWest Palm Beach$7.1M
- Tina ThethiOrlando$3.8M
- David SuttonJacksonville$3.1M
- Lorena Lewy-AlterbaumHollywood$3.1M
- Mae Sheikh AliJacksonville$2.9M
- James MageeJacksonville$2.7M
- Rodolfo GalindoMiami$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.